Client 1:

Biotech start-up company, VC financed

Product:

Biopharmaceutical fusion protein in late preclinical stage of development/ready for IND filing

Indication:

Autoimmune disorders, transplant rejection, RA

Situation:

Company was seeking to commercialize its most advanced development candidate to finance the development of other pipeline candidates.

Company’s business model was to focus on discovery and early development phase. They identify lead compounds and develop them into the preclinical stage (max until phase 2a POC) and then look for licensees.

Objectives:

To partner the most advanced development candidate with a global pharmaceutical corporation that has the appropriate financial, scientific, manufacturing and marketing capabilities and capacities in the indication area to continue with the development and registration of the product and to launch and market the product.

Activities:

Partnering process was divided into 2 steps:

Phase 1:

In-depth analysis of the business and proposal of action plan for next steps

Deliverables: Phase 1 Report

(incl. long list of target companies, action plan incl. timelines)

Phase 2:

Partnering Strategy Project performed as a competitive bidding process

Implementation of action plan

Results:

• Asset Purchase Agreement
• Duration of entire partnering process: 16 months (2 months strategy development and 14 months operational BD process)